Business & Finance
Premier Expands Effort to Supply Shortage Generic Drugs
14 January 2019 - - US-based healthcare improvement company Premier Inc. (NASDAQ: PINC) has established a company to help ensure health systems have continuous and affordable access to shortage medica...
Advaxis announces fiscal 2018 financial results, business update & schedules conference call for 15 January 2019
11 January 2019 - Biotechnology company Advaxis Inc (NASDAQ:ADXS) stated on Thursday its net loss of USD66.5m (USD1.29 per share) for the fiscal year ended 31 October 2018.This marks a rise in earning...
Orion reports on nomination committee's board proposals to AGM 2019
10 January 2019 - Finnish pharmaceutical company Orion Oyj (HEL:ORNBV) announced on Wednesday that its nomination committee, on 9 January 2019, gave its recommendation to the board of directors of the...
Accelerate Diagnostics provides update of preliminary results for Q4 and full-year 2018
7 January 2019 - Diagnostics company Accelerate Diagnostics Inc (NASDAQ:AXDX) said on Sunday that it expects total revenues of approximately USD1.8m for the fourth quarter ending 31 December 2018.This...
3SBio signs biosimilar collaboration agreement with Samsung Bioepis
7 January 2019 - Chinese biopharmaceutical company 3SBio Inc (01530.HK) revealed on Sunday the launch of a collaboration agreement with Samsung Bioepis Co Ltd for the clinical development and commerci...
Lupin and AbbVie Partner to Develop and Commercialise Novel Oncology Drug to Treat Hematological Cancers
27 December 2018 - - US-based biopharmaceutical company AbbVie Inc., has licensed Indian pharmaceutical company Lupin's MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) ...